Results 281 to 290 of about 542,975 (311)
Some of the next articles are maybe not open access.

Advances of Programmed Death-1/Programmed Death-1 Ligand Signal Pathway and its Blockers in Nasopharyngeal Carcinoma

Journal of Genetic Disorders & Genetic Reports, 2018
Nasopharyngeal carcinoma is one of the most common malignancies of head and neck squamous cell carcinoma in southern China and is closely related to Epstein-Barr virus infection. Although the treatment efficacy of nasopharyngeal carcinoma has been made an obvious progress during the recent years, there are still some patients suffering from relapse or ...
openaire   +1 more source

Programmed Death-1 Pathway in Orbital Invasion of Cutaneous Carcinomas

Ophthalmic Plastic & Reconstructive Surgery, 2018
Purpose: The programmed death-1 pathway negatively regulates the immune system. Previous reports have indicated worse tumor-related outcomes with increased expression of the ligand for this pathway. This study was undertaken to assess the role of the PD pathway in cutaneous malignancies that invade the orbit.
Edward J, Wladis   +4 more
openaire   +2 more sources

Molecular cloning and expression analysis of bovine programmed death-1

Microbiology and Immunology, 2010
Recent work has shown that PD-1, an immune inhibitory receptor, is involved in mechanisms for down-regulating immune responses during tumor progression or chronic viral infection. However, in the case of bovine diseases, there have been no reports on this molecule due to lack of information about bovine PD-1.
Ryoyo, Ikebuchi   +4 more
openaire   +2 more sources

[Resistance mechanism of programmed death-1 antibody].

Zhonghua zhong liu za zhi [Chinese journal of oncology], 2018
Accompanied with more elaborate and deeper exploration, immunotherapy has been considered one of the most important therapeutic manners for tumor treatment besides conventional operative, chemotherapeutic, radiotherapeutic and targeted-therapeutic strategies.
D, Xin, F, Wang
openaire   +1 more source

Programmed death 1 immune checkpoint inhibitors.

Clinical advances in hematology & oncology : H&O, 2016
Programmed death 1 (PD-1) is an immune checkpoint that provides inhibitory signals to the immune system in order to modulate the activity of T cells in peripheral tissues and maintain self-tolerance in the setting of infection and inflammation. In cancer, the immune checkpoints are exploited so that the tumor cells are able to evade the immune system ...
Meghna S, Trivedi   +5 more
openaire   +1 more source

The Role of Programmed Death 1 in Systemic Lupus Erythematosus

Journal of Investigative Medicine, 2004
E. Nashi, T. Hudson
openaire   +1 more source

Anti-Programmed Death 1 (PD1)

2013
Gordon J. Freeman, Arlene Sharpe
openaire   +1 more source

Home - About - Disclaimer - Privacy